Molecular Formula:
C82H103ClN18O16
Relative Molecular Mass:
1632.28 g/mol
CAS-Number:
214766-78-6 (net)
Synonym:
FE200486
Sequence:
Ac-D-2-Nal-D-4-Cpa-D-3-Pal-Ser-4-amino-Phe(L-hydroorotyl)-4-ureido-D-Phe-Leu-Lys(isopropyl)-Pro-D-Ala-NH2 acetate salt
Fields of Application:
Advanced hormone-dependent prostate carcinoma
Active Substance:
Degarelix Acetate is an LHRH (GnRH) receptor antagonist, indicated for patients with
advanced prostate cancer. Degarelix reversibly and dose-ependently suppresses
gonadotropin and sex steroid levels by inhibiting the binding of endogenous
LHRH to its receptors.
Degarelix showed to be at least as effective as leuprolide in sustaining levels of
testosterone that are equivalent to or lower than that seen with castration.
This product is offered and sold solely for uses reasonably related to the development
and submission of information under a Federal law which regulates the manufacture,
use or sale of drugs (the “Bolar Exemption”). ISPECHEM cannot be made liable for
any infringement of intellectual property rights. It is the sole and only responsibility of
the purchaser or user of this product to comply with the relevant national rules and
regulations.
關(guān)鍵字: 地加瑞克;醋酸地加瑞克;Degarelix Acetate;Degarelix